CD8A and cancer: A recent study indicated that NK cells pre-activated by IL-12, IL-15 and IL-18 suppress graft-versus-host disease but obviously inhibit the generation and function of CD8+ T cells, which could result from mutual competition of IL-2 [239], limiting its value in the field of cancer treatment.